Page last updated: 2024-12-06
8-hydroxyloxapine
Description
8-hydroxyloxapine is a hydroxylated derivative of the antipsychotic drug Loxapine. It is a potent dopamine D2 receptor antagonist, and has been investigated for its potential therapeutic effects in various neurological and psychiatric disorders, including schizophrenia, depression, and anxiety. The compound exhibits a wide range of pharmacological properties, including antipsychotic, anxiolytic, and antidepressant effects. Research has focused on exploring its mechanism of action, its potential therapeutic applications, and its safety profile. 8-hydroxyloxapine is a promising candidate for drug development, particularly for the treatment of psychiatric disorders.'
8-hydroxyloxapine: active metabolite of loxapine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 43655 |
MeSH ID | M0108101 |
Synonyms (16)
Synonym |
8-hydroxyloxapine |
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepin-3-ol |
2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepin-8-ol |
FT-0669711 |
unii-0q6hmm3xrc |
dibenz(b,f)(1,4)oxazepin-8-ol, 2-chloro-11-(4-methyl-1-piperazinyl)- |
0q6hmm3xrc , |
61443-77-4 |
8-hydroxy loxapine |
2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepin-8-ol # |
VNJRIWXLPIYFGI-UHFFFAOYSA-N |
DTXSID80210387 |
AKOS028114539 |
dibenz[b,f][1,4]oxazepin-8-ol, 2-chloro-11-(4-methyl-1-piperazinyl)- |
Q27237099 |
PD060513 |
Research Excerpts
Bioavailability
Dosage Studied
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.43
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.43 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 2 (40.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (60.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |